hyperplasia of mammary glands
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. women between the ages of 18 and 40 have regular menstrual cycles (28 days plus or MINUS 3 days) and menses; 2. vas > level 3 patients; 3. those who did not receive treatment for hyperplasia of mammary glands within one month, and those who did not use hormone preparations within half a year; 4. informed consent, volunteers and signatories of informed consent.
Exclusion criteria
Exclusion criteria: (1) allergic constitution, scar constitution or serious skin diseases; (2) those who have received other related treatments that may affect the observation indicators of this study; (3) pregnancy, lactation, menopause and women preparing for pregnancy; (4) patients with breast cancer, inflammatory diseases and other endocrine diseases; (5) complicated with cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic system and other serious primary diseases, or psychotic patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Breast Pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Breast Lump;Syndrome of liver depression and qi stagnation; | — |
Countries
China
Contacts
Beijing First Hospital of Integrated Chinese and Western Medicine